Bergera koenigii
Bergera koenigii · Accepted scientific name
Scientific literature: Very Sparse (37 studies) · ★☆☆☆☆
Bergera koenigii, commonly known as curry leaf, is a versatile medicinal plant utilized for its diverse therapeutic activities including antioxidant, antidiabetic, antimicrobial, and anticancer properties. Various parts of the plant, such as the leaf, root, stem, and seed, can be processed into preparations like aqueous extracts or a specific mahanine-enriched fraction (MEF). The plant's medicinal potency is driven by key bioactive chemicals, including flavonoids and specialized alkaloids like mahanine, mahanimbine, and girinimbine. Research highlights its significant effectiveness in managing conditions such as lipid peroxidation, diabetes, and breast cancer. Through these various extracts, the plant serves as a rich natural source for combating complex oxidative and metabolic disorders.
- Synonyms
- Murraya Siamensis · Murraya Koenigii · 6 more
- Common names
- Not available
- Family
- Rutaceae
- Distribution
- Not available
- Plant Parts
- Leaf · Root
Classification
Synonyms
Bergera koenigii is a plant species that has been identified by several different scientific names throughout botanical history. It is frequently listed under the synonym Bergera siamensis, reflecting various taxonomic classifications. Researchers have also documented its relationship to names such as Camunium koenigii and Chalcas koenigii. Furthermore, the plant is associated with the synonyms Chalcas siamensis and Murraya foetidissima in several botanical records. Understanding these various nomenclatural connections is essential for accurate plant identification and study.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Bergera koenigii is a notable botanical specimen that belongs to the kingdom Plantae. Within this vast biological realm, it is classified under the class Equisetopsida. It further resides in the order Sapindales, a group known for its diverse members. As a representative of the genus Bergera, it occupies a specific niche in the natural world. Ultimately, this plant is a distinguished member of the family Rutaceae.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Sapindales |
| Family | Rutaceae |
| Genus | Bergera |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Bergera koenigii exhibits a widespread geographic presence that spans various ecological zones across the continent. Its distribution reaches into the temperate regions of the Arabian Peninsula and the Gulf States. The plant is also extensively found throughout China, including its South-Central, Southeast, and Hainan territories. Furthermore, it thrives within the tropical landscapes of the Indian Subcontinent, particularly in areas such as Assam. This diverse range highlights the remarkable adaptability of the species across different Asian climates.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Bergera koenigii is a self-supporting plant that typically takes the form of a tree. It is characterized by a modest stature, reaching a maximum height of approximately 6 meters. This compact growth habit makes it a distinct feature within its natural environment.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Bergera koenigii, also commonly known as Murraya koenigii, is a medicinal plant belonging to the Rutaceae family that possesses a wide array of pharmacological activities. Research has demonstrated that its extracts exhibit significant antioxidant and antidiabetic properties, making it a valuable resource for managing metabolic health. Furthermore, the plant demonstrates potent antimicrobial effects, including the ability to inhibit the growth of bacteria such as S. aureus and E. coli. Studies also highlight its anticancer potential, particularly through the bioactive alkaloid mahanine, which shows promise in various cancer models. Additionally, the plant has shown documented antimalarial efficacy, reinforcing its importance in traditional and modern therapeutic practices.
Compounds
Bergera koenigii, also commonly known as the curry leaf plant, serves as a rich source of diverse bioactive compounds. This medicinal herb contains several significant carbazole alkaloids, most notably mahanine, which is recognized for its potent anticancer effects. In addition to mahanine, the plant contains mahanimbine and koenimbine, both of which contribute to its complex pharmacological profile. The presence of girinimbine further enhances its therapeutic potential, particularly in studies involving neuroprotective and antiproliferative activities. Finally, the phytochemical landscape of Bergera koenigii is rounded out by the presence of flavonoids, which support its various antioxidant and medicinal properties.
Conditions
Bergera koenigii, also known as Murraya koenigii, provides significant antioxidant benefits through its high total phenolic and flavonoid content. The plant also functions as an effective anti-inflammatory agent, with specific carbazole alkaloids demonstrating the ability to inhibit inflammatory enzymes. Its antimicrobial properties are well-documented, showing high inhibitory activity against bacterial strains such as Staphylococcus aureus and Escherichia coli. Furthermore, the plant exhibits potent anticancer effects, largely driven by the bioactive component mahanine which shows promise in various cancer models. Finally, Bergera koenigii serves as an antidiabetic treatment by demonstrating hypoglycemic activity and regulating blood sugar levels.
Preparations
Bergera koenigii is prepared as extracts, including methanol and ethanol versions, to evaluate various biological activities. It is specifically prepared as an aqueous extract of the leaves to study its hypoglycemic and hepatoprotective effects. Additionally, the plant is prepared as a leaf extract for use in the green synthesis of zinc oxide nanoparticles. For targeted cancer research, Bergera koenigii is prepared as a mahanine-enriched fraction (MEF) to enhance the bioavailability of its bioactive alkaloids. These diverse preparation methods allow for the investigation of its potential in treating diabetes, neurodegeneration, and various types of cancer.
Parts used
Bergera koenigii, also known as Murraya koenigii, is a highly valued medicinal herb that contains bioactive compounds across its various anatomical structures. The leaves are a primary source of significant carbazole alkaloids like mahanimbine and koenimbine, which demonstrate potent anticancer properties. Research also highlights the therapeutic potential of the plant's roots, which exhibit remarkable antibacterial and antifungal activities. Furthermore, the stem provides unique phytochemical profiles, including high antioxidant activity. Finally, the seeds of the plant are noted for containing minor furocoumarins, completing the diverse medicinal profile of this versatile species.